The importance of the p53 pathway in tumor suppression is also highlighted by the observation that TP53 mutations are associated to poor prognosis [6] and they are present in about half of all human cancers, reaching even ~75% of PDAC patients [7,8]. Here, TP53 is linked to cancer.